Considerations for the Clinical Development of Cytokine Gene-Transduced Tumor Cell Vaccines

This publication has 36 references indexed in Scilit:

• Use of Murine Models of Cytokine-Secreting Tumor Vaccines to Study Feasibility and Toxicity Issues Critical to Designing Clinical Trials
  Journal of Immunotherapy, 1995
• A new look for the 1990s
  Nature, 1994
• Role of Bone Marrow-Derived Cells in Presenting MHC Class I-Restricted Tumor Antigens
  Science, 1994
• Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor.
  The Journal of Experimental Medicine, 1992
• A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
  Science, 1991
• Treatment of Established Renal Cancer by Tumor Cells Engineered to Secrete Interleukin-4
  Science, 1991
• High-dose inhibition and low-dose enhancement of murine sarcoma growth exhibited by BCG vaccine
  Cancer Letters, 1991
• Mechanisms of anti-tumor action of Corynebacterium parvum. I. Potentiated tumor-specific immunity and its therapeutic limitations.
  The Journal of Experimental Medicine, 1981
• Expression of a β-globin gene is enhanced by remote SV40 DNA sequences
  Published by Elsevier ,1981
• Inhibitory effect of prolongedcorynebacterium parvum and cyclophosphamide administration on the growth of established tumors
  Cancer, 1975